Bandages made of medical waste cost Medicare $10B last year—limits are coming

In a staggering revelation, Medicare's expenditures exceeded $10 billion last year on questionable bandages known as skin substitutes, which come with astronomical price tags. Some of these products are controversially crafted from medical waste, including remnants from discarded placentas and infant foreskin. Alarmingly, many of these bandages have not undergone comprehensive testing to demonstrate any superiority over traditional bandaging methods. Reports indicate that Medicare has made payments for some bandages that cost over $21,000 per square inch. Moreover, individual patients have accrued bills surpassing $1 million for bandaging alone, in some cases for individuals without any actual wounds. Unlike Medicare, most private insurance providers refuse to cover these bandages, labeling them as "unproven and not medically necessary." The surge in Medicare's spending can be traced back to a regulatory shift in 2020, which permitted a broader application of these skin substitutes, particularly for treating diabetic ulcers. Since the beginning of 2023, an investigative report from The New York Times revealed that over 100 new products have flooded the market. Two primary factors contribute to the exorbitant costs associated with these bandages. Initially, due to an unusual pricing policy, Medicare allows manufacturers to set the reimbursement rate based on their chosen price during the first six months of availability. Additionally, physicians receive significant discounts, which incentivizes them to prescribe these high-cost items for increased reimbursement. After the initial six-month period, reimbursement rates revert to what physicians pay after discounts from manufacturers. However, some manufacturers circumvent these limitations by introducing new products that closely resemble their predecessors, thus preserving the inflated reimbursement rates.